22 May 2024 : Clinical Research
Incidence, Risk Factors, and Outcomes of Left Atrial Enlargement in Patients Requiring Right Ventricular Pacing: A Retrospective Study of 461 Cases from 2012 to 2020
Wei-Chieh Lee
123ABCDEF*, Wei-Ting Chang123CD, Hsiu-Yu Fang45B, Huang-Chung Chen 4B, Mien-Cheng Chen4EF, Ping-Yen Liu16EF
DOI: 10.12659/MSM.944114
Med Sci Monit 2024; 30:e944114
Table 1 Baseline characteristics between patients without and with significant LAE.
| Without significant LAE | With significant LAE | P value | |
|---|---|---|---|
| 365 | 96 | ||
| Age (years) | 71±11.9 | 70±15.9 | 0.486 |
| Male sex (%) | 183 (50.1) | 53 (55.2) | 0.422 |
| BMI (kg/m) | 23.12±6.54 | 22.68±7.06 | 0.562 |
| Hypertension (%) | 261 (71.5) | 70 (72.9) | 0.899 |
| DM (%) | 140 (38.4) | 31 (32.3) | 0.288 |
| CAD (%) | 64 (17.5) | 14 (14.6) | 0.544 |
| Hyperlipidemia (%) | 81 (22.2) | 12 (12.5) | 0.045 |
| ESRD (%) | 18 (4.9) | 5 (5.2) | 0.912 |
| Prior stroke (%) | 46 (12.6) | 15 (15.6) | 0.498 |
| 3.3±1.7 | 3.3±1.7 | 0.870 | |
| 166.98±17.65 | 164.75±21.32 | 0.376 | |
| 0.363 | |||
| Lower septum or apex (%) | 60 (16.4) | 20 (20.8) | |
| High septum or near RVOT region (%) | 305 (83.6) | 76 (79.2) | |
| ACEI/ARB (%) | 271 (74.2) | 71 (74.0) | 0.954 |
| β-blocker (%) | 59 (16.2) | 13 (13.5) | 0.636 |
| Statin (%) | 119 (32.6) | 23 (24.0) | 0.108 |
| 6.7±4.9 | 8.0±4.6 | 0.019 | |
| Data are expressed as mean (standard deviation) or as number (percentage). LAE – left atrial enlargement; DM – diabetes mellitus; BMI – body mass index; CAD – coronary artery disease; ESRD – end-stage renal disease; RV – right ventricle; RVOT – right ventricular outflow tract; ACEI – angiotensin-converting enzyme inhibitor; ARB – angiotensin II receptor blocker; F/U – follow-up. | |||